Richard Parker

Latest

• The placebo response in randomised trials in nonalcoholic steatohepatitis simply explained
• Fibrosis progression rate in a systematic review of placebo-treated nonalcoholic steatohepatitis
• High rates of ineligibility for participation in trials of new therapies in nonalcoholic steatohepatitis, a systematic review
• Natural history of histologically proven alcohol-related liver disease, a systematic review